Sep 01, 2023 / Comment Letters MedPAC comment on CMS’s proposed rule on the remedy for the 340B-acquired drug payment policy for calendar years 2018-2022 Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing
Aug 25, 2023 / Comment Letters MedPAC comment on CMS’s proposed rule on the home health prospective payment system for CY 2024 Research Areas: Medicare Spending and Financing, Post-Acute Care
Aug 25, 2023 / Comment Letters MedPAC comment on CMS’s proposed rule on the end-stage renal disease payment system for CY 2024 Research Areas: Ambulatory Care Settings, Medicare Spending and Financing
Aug 25, 2023 / Comment Letters MedPAC comment on CMS’s notice on transitional coverage for emerging technologies Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests
Jul 26, 2023 / Data Book July 2023 Data Book: Health Care Spending and the Medicare Program Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jul 26, 2023 / Data Book July 2023 Data Book, Section 1: National health care and Medicare spending Research Areas: Beneficiaries and Coverage, Medicare Spending and Financing
Jul 26, 2023 / Data Book July 2023 Data Book, Section 2: Medicare beneficiary demographics Research Areas: Beneficiaries and Coverage
Jul 26, 2023 / Data Book July 2023 Data Book, Section 3: Medicare beneficiary and other payer financial liability Research Areas: Beneficiaries and Coverage, Medicare Spending and Financing, Private Plans
Jul 26, 2023 / Data Book July 2023 Data Book, Section 4: Dual-eligible beneficiaries Research Areas: Beneficiaries and Coverage
Jul 26, 2023 / Data Book July 2023 Data Book, Section 5: Alternative payment models Research Areas: Delivery System Reforms, Physicians And Other Health Professionals